8 news items
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $8 Price Target
PCSA
13 May 24
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $8 price target.
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
ACON
BYD
CSSE
26 Apr 24
50% on Thursday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
ATNI
BMY
HTZ
25 Apr 24
price target.
Equities Trading DOWN
ATN International, Inc
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
ACON
AIRE
ATNI
25 Apr 24
% to $2.2250 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.
Aclarion
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
ATNI
HTZ
MRK
25 Apr 24
coverage on the stock with a Buy rating and announced an $8 price target.
Equities Trading DOWN
ybkwb3k1g1ekgphkkwd7odx9g7g xqwym5440l6f3
BRFH
CSSE
HRYU
25 Apr 24
after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.
Equities
8n8i7oqhmem2 j5ucd0dbsrd6ghohn7otduwajclhbvcn5
PCSA
25 Apr 24
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Processa Pharma (NASDAQ:PCSA) with a Buy rating and announces Price Target of $8.
f9hrfb vb35z2
PCSA
6 Mar 24
Benchmark analyst Robert Wasserman reiterates Processa Pharma (NASDAQ:PCSA) with a Speculative Buy and maintains $4 price target.
- Prev
- 1
- Next